dpp4 vs sglt2 vs glp-1 Clinical Use of DPP-4 Inhibitors Safety of SGLT2 inhibitors, DPP-4

Obesity is a growing epidemic that affects millions of people worldwide, leading to serious health complications such as heart disease, diabetes, and certain cancers

You grab whatever's convenient, then feel guilty about derailing your progress again

Learn how to become a GLP-1 nutrition counseling specialist

Conclusions While GLP-1 receptor agonists do not appear to significantly increase overall surgical risks, their effects on tissue healing and bruising warrant further investigation

As more evidence becomes available on the GLP-1s, expect the halo impact on overlapping comorbidities to accelerate their adoption